AstraZeneca Admits Rare Side Effect in Covishield Vaccine Amid UK Lawsuits

The pharmaceutical giant acknowledges that its COVID-19 vaccine can cause thrombosis with thrombocytopenia syndrome (TTS) in rare instances, as legal battles intensify.

• AstraZeneca is currently facing a class action lawsuit in the UK, with claims that the Covishield vaccine has caused deaths and severe injuries.
• The company admitted in court documents that the vaccine can, in very rare cases, lead to a condition causing blood clots and low platelet counts.
• Victims are seeking damages up to 100 million pounds in the UK High Court, with individual cases potentially worth millions.
• AstraZeneca maintains that the vaccine's benefits outweigh the risks, citing its role in saving millions of lives globally during the pandemic.
• The UK government may bear the financial responsibility for any payouts due to a previous agreement with AstraZeneca.

4 Articles

NDTV NDTV New York Post mint